No differences were observed in the primary disease, medications, dialysis vintage, and AVF blood flow in patients receiving MHD with different LVGs, whereas PTH and BNP levels were higher in the CH subgroup than in the other subgroups. This evidence concerns the gene NPPB and cyclic hematopoiesis.